GLONGHUI, April 18 | Consumer genetics research company 23andMe Holding Co., US stocks rose more than 44.58% at the beginning of the market, which is expected to end the previous six-day decline and report at $0.5150, breaking away from the intraday low of $0.35 since the US IPO in June 2021. Anne Wojcicki, CEO of the DNA testing company, told board members that she is considering privatizing the struggling company.
美股异动丨23andMe一度涨超44%，CEO考虑私有化
Changes in US stocks: 23andMe once rose more than 44%, CEO considering privatization
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.